Form D · Biotechnology
Trefoil Therapeutics, Inc.
El Cajon, CA · CIK 0001691855
Offering snapshot reported May 7, 2025 · SEC filing
- Reported sold
- $4.56M Offering amount: $5M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 23, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 7, 2025 | Initial | $4,559,996 | No comparison | 16 | SEC filing |
| Mar 22, 2022 | Initial | $11,970,548 | No comparison | 14 | SEC filing |
| Aug 5, 2019 | Amendment | $12,604,500 | $1,579,501vs Jul 17, 2019 | 13 | SEC filing |
| Jul 17, 2019 | Initial | $11,024,999 | No comparison | 10 | SEC filing |
| Dec 8, 2016 | Initial | $4,163,999 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-545445
Source: Form D, filed May 7, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ralph Bradshaw | Director |
| David Eveleth | Director, Executive |
| John Fucci | Director |
| Ben Mc Graw | Director |
| Jonathan Mow | Executive |
| Schalon Newton | Executive |
| Stella Robertson | Director |
| Christy Shaffer | Director |
| Kseniya Simpson | Director |
| Derek Yoon | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/O Dodson And Dodson 14417 Ranch Trail Drive
El Cajon, CA, 92021
El Cajon, CA, 92021